HNGE stock consolidates near $93.12 entry after surging 7% on strong earnings and revenue growth.
Hinge Health (HNGE) shares traded at $89.84, up $1.60 or 1.81%, pausing after a post-earnings rally. The stock eyes a potential buy point at the Aug. 11 high of 93.12, driven by robust earnings and revenue growth.
The stock holds an IBD Composite Rating of 77 out of 99 and ranks 12th in its industry group of 197. Analysts noted a consolidation pattern forming, which may precede further upside if the stock breaks out.
No immediate market reaction details were provided, but the stock’s momentum follows broader sector trends tied to earnings performance.